BBI Europe Ltd (Bruin Biometrics) is a pioneer in sensor based medical devices and is committed to the development of assessment devices for early identification and monitoring of chronic, preventable conditions. Our mission is to modernise care pathways through developing and collaboratively integrating new-to-the-world biometric-sensor based medical devices. The company's lead product is the SEM Scanner, a hand-held wireless device that identifies increased risk of pressure ulcers 5 days* earlier1 than visual skin assessment
The SEM Scanner is commercially available in the following countries UK and Ireland; Australia, Spain, Portugal, Belgium, Luxembourg, Australia, New Zealand, Canada and the USA.
1. Okonkwo H. et al NPUAP 2018
The HARTMANN GROUP is one of the leading European providers of medical and hygiene products with a focus on wound care, incontinence care and infection protection. The portfolio also includes products for compression therapy, first aid, and nursing and cosmetic products.
Our wound management treatments are the result of HARTMANN`s 200 year medical experience, ensuring effective and scientifically verified solutions. HARTMANN offers medical devices for wound care that make health economic sense and bring simplicity to patients and care givers’ lives. In addition, HARTMANN offers innovative system solutions for professional target groups in the medical and healthcare sectors.
With its subsidiaries around the world, the Heidenheim-based company, which focuses primarily on the European market, ensures it is always in close contact with its customers.
Mölnlycke is a world-leading medical solutions company.
We’re here to advance performance in healthcare across the world, and we aspire to equip everybody in healthcare with solutions to achieve the best outcomes.
We collaborate with customers to understand their needs. We design and supply medical solutions to enhance performance at every point of care – from the operating room to the home.
“SANUWAVE Health, Inc. is an emerging leader in the development and commercialization of shockwave technology used for the repair and regeneration of bones, muscles, tendons and skin, and for the separation of solids and fluid in non-medical systems. Within healthcare, SANUWAVE’s proprietary, patented Pulsed Acoustic Cellular Expression (PACE®) technology emits high-energy, acoustic shockwaves based upon electrohydraulic principles that restore the body’s normal healing processes.
SANUWAVE has two devices that employ PACE® technology. The lead device for the global wound care market, the dermaPACE® System, is the only focused Extracorporeal Shock Wave Therapy (ESWT) cleared by the FDA for the treatment of Diabetic Foot Ulcers (DFU). The dermaPACE® System is CE Marked in Europe for advanced wound care indications. Additionally, the dermaPACE® System and wound indications are currently licensed or approved in Canada, Australia, New Zealand, countries in SEA and South Korea. SANUWAVE’s second PACE® device, the orthoPACE® System, is CE Marked in Europe for orthopedic and musculoskeletal indications.”
Because wounds are a source of suffering, our mission as “the Healing Company” is to support healthcare professionals every day in delivering evidence-based treatments from the beginning so that life can start again for patients.
At Urgo Medical, we strongly believe that we can make a difference by:
· Putting patients at the heart. We give a voice to patients so we can understand their needs and adapt our solutions to better meet them.
· Being the professional’s partner. We work closely with scientific bodies and we develop educational programs to constantly improve knowledge in advanced wound care.
· Leading with Science. We continually invest in R&D and deliver robust clinical evidence because we believe in evidence-based treatments.
We can do it because our 1300 employees are passionate about making a difference for patients